Paraoxonase 1 (PON1) protects against oxidative modification of low density lipoproteins. The PON1 gene has 3 polymorphisms considered strong determinants of PON1 levels: Q192R and L55M in the coding region and C-108T in the promoter region. PON1 levels are also influenced by smoking. The authors hypothesized that PON1 variants could increase the risk of vascular thrombosis, leading in turn to placental insufficiency and small-for-gestational-age (SGA) birth. The author compared PON1 variants and haplotypes between 448 newborn SGA cases and 431 newborn controls from Montré al, Qué bec, Canada (1998 and studied the effects of interaction with maternal smoking. Transmission of the variants in case-parent trios was used as validation of the case-control results; the authors combined case-control and family data to analyze the associations of variants with SGA birth. In the case-control analysis, the T allele from C-108T increased the risk of SGA birth (additive odds ratio ¼ 1.30, 95% confidence interval (CI): 1.06, 1.59), and the TRL haplotype (T from C-108T, R from Q192R, and L from L55M) was associated with an odds ratio of 1.51 (95% CI: 1.07, 2.15). Among smokers, the CRL haplotype was protective (odds ratio ¼ 0.48, 95% CI: 0.28, 0.82). Case-parent trio results were compatible with case-control results.
Paraoxonase 1 (PON1) is a high density lipoprotein (HDL)-bound arylesterase that protects against oxidative modification of low density lipoprotein (LDL). This effect occurs through the catalytic action of PON1, which in vitro reduces lipid peroxide generation by hydrolyzing biologically active LDL (1, 2) . A number of in vitro (3) (4) (5) and in vivo (6, 7) studies have now shown an inverse relation between the level of oxidized lipid products and PON1 activity. Furthermore, Shih et al. (8) showed that PON1-deficient knockout mice were unable to prevent oxidation of LDL, while the activity was restored by the addition of purified PON1, and significantly increased the extent of atherosclerosis lesion development. More recently, lactones and their derivatives have been shown to be the principal substrates for PON1 (9) (10) (11) . This observation suggests a diversity of physiologic mechanisms, while the link with vascular disease and lipid oxidation remains via derivatives of the oxidized fatty acids (11) implicated in the inflammatory response; the latter is relevant to atherosclerosis, which is now considered a chronic inflammatory disease (12) .
The PON1 gene has 2 common polymorphisms within the coding region resulting in amino acid substitutions (13) : The first involves a change of methionine (M allele) for leucine (L allele) at position 55 (L55M), and the other involves a change of arginine (R allele) for glutamine (Q allele) at position 192 (Q192R). These polymorphisms are also referred to as rs854560 and rs662, respectively. There are other common polymorphisms in the promoter region, among which is C-108T (rs705379) (sometimes called -107; see Furlong et al. (14) for comments on nomenclature). The M allele at position 55 has been associated with low plasma PON1 levels, but this seems to be due mainly to linkage disequilibrium between this single nucleotide polymorphism and the C-108T polymorphism. The latter is seen as the almost exclusive determinant of promoter-related variations (15, 16) . The T allele at position 108 produces PON1 levels that are almost twice as low as those seen with the C allele. On the other hand, the R allele at position 192 is less efficient at metabolizing oxidized HDL and LDL than the Q allele (17) . Although these PON1 variants are considered the strongest determinants of the PON1 phenotype, other factors such as smoking and alcohol consumption also influence PON1 levels (18) . Thus, the potential effect of interaction between genetic and lifestyle determinants on outcomes thought to be associated with PON1 levels is of interest.
The relation between PON1 activity and oxidized LDL recently led Chen et al. (19) to hypothesize that variants in the gene could be related to vascular endothelial damage, placental insufficiency, and thrombosis and thus could lead to adverse pregnancy outcomes. Eighty-five infants born preterm and 105 infants born at term were studied, and parental DNA was collected. The infant Q192R variant was associated with increased risk of preterm delivery (relative risk ¼ 3.6, 95% confidence interval (CI): 1.3, 11) (19) . Other investigators recently studied the associations between Q192R and self-reported pregnancy-induced hypertension, gestational hyperglycemia, and premature first birth (20) . There was no association between the variant and the 2 former outcomes, but the odds ratio for reported preterm birth increased with each R allele (odds ratio (OR) ¼ 1.20, 95% CI: 1.03, 1.41).
To the best of my knowledge, no study has specifically considered the relation between newborn PON1 variants and small-for-gestational-age (SGA) birth. Thus, my colleagues and I carried out a genetic association study to evaluate the effects of 3 functional PON1 variants (L55M, Q192R, and C-108T) on SGA birth, defined as birth weight below the 10th percentile for gestational age and sex, according to national standards. Although there is a wide breadth of possible etiologic hypotheses, our main underlying hypothesis, supported by previous findings (8, 21, 22) , was that PON1 variants can increase the risk of vascular thrombosis, which in turn can lead to placental insufficiency and small infants. We compared individual single nucleotide polymorphisms and haplotype frequencies in newborn cases and controls and assessed their transmission in case-parent trios. Regardless of whether the frequency of a variant is compared between unrelated cases and controls or its transmission is assessed using a case-parent trio study, the goal remains the same-that is, to estimate genetic risk associated with the variant (23) . Therefore, we used genetic data from related and unrelated study subjects to calculate a combined risk estimate for each variant. In addition, since maternal smoking is an established determinant of smallness for gestational age (24) and smoking is known to influence PON1 levels in addition to these PON1 variants, we studied the effect of interaction between the newborn variants and maternal smoking on SGA birth.
MATERIALS AND METHODS

Study population and data collection
The study was initiated as a case-control comparison of mother and newborn dyads with and without SGA birth, and we extended the data to form case-parent trios by including genetic material obtained from fathers (25) (26) (27) (28) . All SGA infants (as defined above) seen at our university center in Montréal, Québec, Canada, between May 1998 and June 2000 were eligible if they were singletons who were born alive after the 24th week of gestation without severe congenital anomalies. During that period, 505 case mothers were seen and 493 (98%) participated in the study. The same criteria applied to the selection of control mothers (defined as women whose babies' birth weights were at or above the 10th percentile for gestational age and sex). Controls were matched to cases on gestational week, sex, and race/ ethnicity and were selected for having a birth date closest in time to the case's. The mothers of 480 controls were invited to participate, and 472 (98%) accepted. The present analysis was based on the availability of newborn blood samples: Blood was obtained from 448 case newborns (91% of participants and 89% of eligible persons) and 431 control newborns (91% of participants and 90% of eligible persons). A face-to-face interview, mainly about potentially confounding factors, was carried out at the hospital in French or English with all mothers of cases and controls, generally within 2 days of delivery. In particular, we asked women about the number of cigarettes smoked per day and the number of glasses of beer, wine, or spirits consumed per day during the month before pregnancy and during each trimester, as well as about chronic diseases present prior to pregnancy and health problems arising during pregnancy (e.g., diabetes, hypertension) that could affect fetal growth. Medical records were used to determine gestational age on the basis of the obstetrician's assessment from ultrasound and other clinical data.
Maternal and umbilical cord blood samples were collected. Approximately midway through the study, we started prospectively collecting DNA samples from fathers. We obtained genetic material from 260 case fathers, representing a response rate of approximately 86% among those fathers invited to participate and 53% of all cases.
The project was approved by the institutional review board of the hospital. An informed consent form was signed by the mother for collection of umbilical cord and maternal blood and by the father for collection of his own genetic material.
DNA samples and genotyping
Cell pellet or buccal swab samples were obtained from study participants. Procedures used for extracting DNA in the different samples are described in detail elsewhere (29) . Genotyping was performed by means of allele-specific polymerase chain reaction (PCR) with the sets of primers shown in the Appendix Table. We used allele-specific PCR amplification of the target sequence followed by fluorometric detection of the PCR product using the intercalating dye SybrGreen I, as described by Moran et al. (30) . Reactive and PCR conditions are also given in the Appendix Table, and additional details can be found in the paper by InfanteRivard et al. (29) . We assessed the accuracy of our genotyping data by analyzing at least 90 blinded duplicates per batch. We performed the duplicate analysis with a new primer set (to detect the polymorphism on the other DNA strand) in order to detect any other mutation located on the primers. We also monitored quality by comparing the raw data values and their dispersion within batches and between batches with the values and dispersion obtained during assay validation. The laboratory personnel were blind to the case/ control status of study subjects.
Statistical analysis
Case-control analysis. Newborn individual PON1 variants and PON1 haplotypes were analyzed, and interaction between newborn haplotypes and maternal smoking was assessed. Pairwise linkage disequilibrium was analyzed using the software SNPAlyze (Dynacom, Mobara, Japan). The linkage disequilibrium statistic D# was calculated for each pair of variants and tested with a chi-squared statistic.
For the individual PON1 variants, odds ratios and 95% confidence intervals were calculated using unconditional logistic regression analysis, with all study subjects included and adjustment for the matching factors. Adjustment and nonadjustment for gestational age and sex produced identical results, because both variables were accounted for in the definition of smallness for gestational age. Therefore, we fitted a first model that included only race/ethnicity as a matching variable and the newborn genotype. The second model included race/ethnicity, newborn genotype, prepregnancy body mass index (weight (kg)/height (m)
2 ), parity, and maternal smoking during the third trimester (defined as any daily smoking vs. none). Use of number of cigarettes smoked per day or smoking in other trimesters did not produce results different from those obtained with any amount of smoking during the third trimester, so we used only the latter variable. Alcohol consumption did not materially change the results, so it was not retained in the model; likewise for maternal diseases. Hardy-Weinberg equilibrium was tested among newborn controls within racial/ethnic groups (31) .
Retrospective semiparametric profile-likelihood methods for analyzing case-control haplotype data in the presence of environmental factors have been developed (32, 33) and implemented for the specific case of a single candidate gene, assuming haplotype-environment independence in the population (34) . It was used to estimate the effect of the newborn haplotypes on the PON1 candidate gene and the interaction of haplotypes with maternal smoking. Percentages of smoking dropped slightly with pregnancy trimesters, the third trimester having the lowest percentage (Table 1) . Nevertheless, we used maternal smoking during the third trimester to assess interaction because it implied smoking throughout pregnancy. We used a likelihood ratio statistic comparing models with and without interaction terms to determine the statistical significance of the interaction. The additive haplotype models were adjusted for race/ ethnicity, prepregnancy body mass index, parity, and smoking during the third trimester. Only haplotypes with frequencies greater than 5% were included in the analysis, and the reference category was the CQL haplotype (C from C-108T, Q from Q192R, and L from L55M).
Analysis of cases and controls with case-parent trios. Recently, methods that combine data from unrelated study subjects as well as related subjects have been proposed in order to increase efficiency in the estimation of a genetic effect (23) . These methods differ from currently available meta-analysis methods in that they do not require independent samples. One such approach was proposed by Chen and Lin (35) . A log odds ratio is estimated from the case-control data using logistic regression with a gene-dose model (additive model), and the conditional-on-parentalgenotype (CPG) likelihood (36) is used to estimate a genotype relative risk (GRR) with the case-parent trio data. The estimates obtained from separate analyses are combined into an overall risk estimate. A weighted least-scores approach is used to combine the odds ratio from the casecontrol comparison and the trio GRR. The weights are a function of the odds ratio and GRR variance and a robust covariance estimate. The robust variance estimate is used to adjust for the correlation between the 2 risk estimates. The method is currently applicable only with complete trios; it resulted in the inclusion of 217 case-parent trios for C-108T (83% of the families with participant fathers and 44% of case families), 227 trios for Q192R (87% and 46%, respectively), and 228 trios for L55M (88% and 46%, respectively). A GRR estimate from case-parent trio analysis is immune to population structure bias, through conditioning on parental genotype (provided that they are complete), while an odds ratio resulting from case-control analysis is not. Valid application of the hybrid approaches therefore requires that population structure be addressed. Chen and Lin (35) compared odds ratio (case-control) and GRR (trios) estimates from logistic regression and the CPG likelihood, respectively, to test the null hypothesis of no population structure. Table 1 shows the characteristics of all available cases and controls. Case and control newborns were similar in sex distribution, gestational age, and race/ethnicity by study design. Among risk factors for SGA birth, case mothers had lower body mass indices and were more often primiparous. Cigarette smoking before pregnancy was common (31% among case mothers and 27% among control mothers). In all trimesters, more case mothers than control mothers smoked.
RESULTS
The distribution of genotypes among the different racial/ ethnic groups of case and control newborns is provided in Table 2 . Hardy-Weinberg equilibrium was tested among controls within racial/ethnic groups and was not rejected. Strong linkage disequilibrium was observed between Q192R and L55M (D# ¼ 0.71 in all cases and D# ¼ 0.89 in Caucasians); C-108T and L55M had D# values of 0.49 for all subjects and 0.53 for Caucasians. Finally, D# was 0.22 for linkage disequilibrium between C-108T and Q192R. All linkage disequilibrium indices were highly statistically significant (results not shown). Table 3 shows that risk of SGA birth was increased among heterozygous offspring for the promoter variant (C-108T) but not for the 2 coding region variants. In an analysis contrasting the associations between the variants and SGA birth according to gestational age (36 weeks and 37 weeks), no statistically significant heterogeneity was observed (results not shown). Nevertheless, the association for C-108T was somewhat stronger in the 37-weeks gestational age group (OR ¼ 1.34, 95% CI: 1.06, 1.69) than in the 36-weeks group (OR ¼ 1.17, 95% CI: 0.75, 1.82). Maternal smoking was associated with an increased risk of SGA birth: Odds ratios were 1.53 (95% CI: 1.07, 2.21) for 1-20 cigarettes/day and 3.95 (95% CI: 1.38, 11.30) for more than 20 cigarettes/day. The odds ratio for any smoking was 1.68 (95% CI: 1.18, 2.38). There was no heterogeneity between smokers and nonsmokers for the effect of individual newborn PON1 variants (results not shown).
Case-control results
The TRL newborn haplotype (T from C-108T, R from Q192R, and L from L55M) was associated with an increased risk of SGA birth (Table 4) , whereas other haplotypes were not. In addition, there was significant interaction between maternal smoking (any vs. none) and the CRL newborn haplotype (C from C-108T, R from Q192R, and L from L55M): Among newborns whose mothers smoked, having at least 1 copy of the CRL haplotype was associated with a lower risk of SGA birth (OR ¼ 0.48, 95% CI: 0.28, 0.82).
Case-control results with case-parent trio data Table 5 presents the results for the hybrid approach (35) . Additive logistic regression was used in case-control analysis, and CPG analysis was used with the case-parent trio data. We contrasted estimates to determine whether there was population stratification. The test was comfortably nonsignificant, suggesting that a combined estimate was valid. These analyses used only complete trios and cases from complete trios in the case-control estimate, which explains the slight differences in the additive odds ratio estimates in comparison with those shown in Table 3 . The GRR results from the case-parent trios were similar to the odds ratios from the case-control analysis; likewise for the combined estimates, which included the null value in the 95% confidence interval for the risk parameter. 
DISCUSSION
Overall results in this study indicated that the T allele of the C-108T functional promoter variant, previously reported to increase the risk of cardiovascular disease (8, 22) , is a determinant of the occurrence of SGA birth. We showed this by comparing frequencies of individual variants and of haplotypes between case and control newborns. With respect to the haplotype comparisons, an increased risk of SGA birth was associated with the TRL haplotype. There was also apparent protection from the effects of maternal smoking among newborns carrying at least 1 copy of the CRL haplotype.
The main incentive for collecting genetic material from case families is related to validity of inferences. Casecontrol studies may have become the preferred design for genetic association studies, but the validity of inferences based on family transmission of alleles makes the trio results attractive. The ability to then combine case-control and case-parent genotype results in order to potentially gain efficiency and to formally check for population structure bias is an additional advantage. Our results from the analysis of individual variant transmission in case-parent trios as well as the combined results (trios with case-control data) were obtained with much smaller numbers of subjects than the case-control results. Statistical power was thus limited, but all results were compatible, although small differences were observed for C-108T. It was reassuring that no population structure bias (confounding by racial/ethnic group) was detected in the estimates from unrelated persons in the case-control data; however, here also statistical power was probably limited (23) , and there could remain some confounding, which may be more important for C-108T. From a methodological standpoint, the results suggest that the case-control approach may be more sensitive than the trio approach for individual variants.
PON1 is highly expressed in human fetal tissues such the liver and pancreas (37) . In adult studies, gene expression is greatly influenced by the C-108T promoter polymorphism. It accounts for up to 25% of intraindividual variations in serum concentrations and activities of the PON1 enzyme (15) . Among unaffected subjects, highly significant differences in serum HDL cholesterol and apolipoprotein A-I concentrations (both components help clear cholesterol from arteries) were observed as a function of the polymorphism, with carriers of the CC genotype having significantly increased concentrations of both substances. However, no association was found between the Q192R and L55M genotypes and these variables (38) . We suggest that there may be a link between PON1 variants affecting vascular parameters and SGA birth, since small size at birth has been associated with health problems in adulthood, such as coronary heart disease and dyslipidemia (39, 40) . That association (often referred to as the Barker hypothesis) is now considered robust and possibly causal (41), although exact mechanisms are unknown. We previously reported a finding supporting the Barker hypothesis when we found a deficit in the transmission of apolipoprotein E allele 2-an allele that is considered protective against coronary heart disease-in SGA newborns (26) .
PON1 polymorphisms have also been studied in relation to longevity and survival. In one such study, the R allele (Q192R) variant and the LL genotype (L55M) conferred a survival advantage (42) . The investigators speculated that despite a rather consistently reported association between the relative risk genotype and increased risk of cardiovascular disease, the mechanism through which the R allele confers a survival advantage may be higher enzymatic activity using paraoxon as a substrate (18) and its role in the metabolism of toxic chemicals. Likewise, we could speculate from our own results showing that the CRL haplotype confers protection against SGA birth among mothers who smoke based on a better fetal response to toxic chemicals (via the R and L alleles) and a better defense against oxidization of LDL via the C allele. Thus, the relation between PON1 polymorphisms and SGA birth is likely to be complex; the same alleles at a given PON1 locus indicate potentially protective or deleterious effects, depending on the metabolic pathway (e.g., toxic chemicals or atherosclerosis) and even on the substrate in that pathway (43) .
Selection bias was unlikely in this study, based on the high participation rates and the availability of genetic material among eligible study subjects. Fathers recruited to provide genetic material were also very responsive. Nonetheless, with respect to genetic trio (or complete trio) data, the numbers included in the analyses were markedly reduced in comparison with the numbers of eligible persons. However, methods based on transmission distortion are not vulnerable to selection bias, except under an unlikely scenario in which the decision to participate is influenced by which alleles the parents happen to have transmitted to their offspring. Population structure bias is the most likely confounding bias in a genetic association study using a casecontrol approach. However, we adjusted for race/ethnicity and tested for this bias in the analysis, finding no evidence for it. Nevertheless, residual confounding undetected by a test with probable low power is still possible. Another study limitation is that the case group was probably heterogeneous, including growth-retarded as well as constitutionally small babies, which may have reduced our ability to uncover strong associations. Finally, a better indication of the metabolic functions of PON1 could have been be obtained by measuring not only the genotypes but also the plasma activity of PON1 (44) .
In conclusion, although the results from this study will need confirmation, they uncover a role for common PON1 variants in SGA birth, particularly the C-108T variant in the promoter region and the haplotype including the T allele from C-108T, the R allele from Q192R, and the L allele from L55M. On the TRL haplotype, the R allele known to be associated with cardiovascular disease could participate in increasing the risk of SGA birth, whereas on the CRL haplotype it could be protective among women who smoke. This mechanism may operate through the established effect of the R allele's enhanced catalytic activity on toxic substrates. The link between PON1 activities in the metabolism of HDL and LDL and SGA birth is hypothesized to operate through long-term effects on the development of chronic diseases in babies who are born SGA.
